EV/EBITDA:
-2.53+0.15(+5.60%)Summary
- As of today, RXRX EV/EBITDA is -2.53, with a rise of +0.15 (+5.60%) during the most recent trading session on December 19, 2025.
- Over the past year, RXRX EV/EBITDA has increased by +3.06 (+54.74%).
- RXRX EV/EBITDA is now -53.33% below its all-time high of -1.65.
Performance
RXRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RXRX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +5.6% | -5.4% | -4.0% |
| 1M1 Month | -7.7% | +7.7% | +5.7% |
| 3M3 Months | +13.1% | -3.9% | -13.2% |
| 6M6 Months | +20.2% | -1.8% | -16.6% |
| YTDYTD | +48.9% | -25.3% | -37.0% |
| 1Y1 Year | +54.7% | -19.8% | -30.1% |
| 5Y5 Years | - | - | - |
RXRX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -2.21 | -14.5% | -3.06 | +17.3% |
| 3M | 3-Month | -2.21 | -14.5% | -4.27 | +40.8% |
| 6M | 6-Month | -2.21 | -14.5% | -4.27 | +40.8% |
| 1Y | 1-Year | -2.21 | -14.5% | -8.77 | +71.2% |
| 3Y | 3-Year | -1.89 | -33.9% | -11.36 | +77.7% |
| 5Y | 5-Year | -1.65 | -53.3% | -90.16 | +97.2% |
| All-Time | All-Time | -1.65 | -53.3% | -90.16 | +97.2% |
RXRX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.53(+48.9%) |
| 2024 | -4.95(+18.3%) |
| Date | Value |
|---|---|
| 2023 | -6.06(-43.3%) |
| 2022 | -4.23(+69.5%) |
| 2021 | -13.86 |
FAQ
- What is Recursion Pharmaceuticals, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Recursion Pharmaceuticals, Inc.?
- What is RXRX EV/EBITDA year-to-date change?
- What is Recursion Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Recursion Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of RXRX is -2.53
What is the all-time high EV/EBITDA for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high EV/EBITDA is -1.65
What is RXRX EV/EBITDA year-to-date change?
Recursion Pharmaceuticals, Inc. EV/EBITDA has changed by +2.42 (+48.89%) since the beginning of the year
What is Recursion Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, RXRX EV/EBITDA has changed by +3.06 (+54.74%)